Back
Biosciences and Biotechnology
LLNL, DOD, NNSA dedicate Rapid Response Laboratory and supercomputing system to accelerate biodefense
Lawrence Livermore National Laboratory (LLNL) recently welcomed officials from the Department of Defense (DOD) and National Nuclear Security Administration (NNSA) to dedicate a new supercomputing system and Rapid Response Laboratory (RRL). DOD is working with NNSA to significantly increase the computing capability available to the national biodefense programs. The…
LLNL honors 23 as Distinguished Members of Technical Staff
Twenty-three LLNL researchers have been named Distinguished Members of Technical Staff (DMTS) for their extraordinary scientific and technical contributions, as acknowledged by their professional peers and the broader scientific community. As distinguished citizens of the Laboratory and their scientific areas of specialization, DMTS honorees have a sustained history of…
Three selected as Graduate Student Research program recipients
Three graduate students have earned Department of Energy (DOE) Office of Science Graduate Student Research (SCGSR) Program awards to perform their doctoral dissertation research at Lawrence Livermore National Laboratory (LLNL). The prestigious award helps cover living expenses and travel for 60 students from universities across the nation. Their proposed research projects…
LLNL and BridgeBio announce trials for supercomputing-discovered cancer drug
In a substantial milestone for supercomputing-aided drug design, Lawrence Livermore National Laboratory (LLNL) and BridgeBio Oncology Therapeutics (BridgeBio) today announced clinical trials have begun for a first-in-class medication that targets specific genetic mutations implicated in many types of cancer. The development of the new drug — BBO-8520 — is the result of…
Finding Livermore: Employees share their LLNL origin stories
With more than 70 years of history and nearly 9,000 current employees, it is not uncommon for several generations of family members to have worked at Lawrence Livermore National Laboratory (LLNL). For those employees with parents or grandparents preceding them, a career at the Laboratory was not in their original plans. In fact, before coming to LLNL, many do not realize…
GUIDE team develops approach to redesign antibodies against viral pandemics
In a groundbreaking development for addressing future viral pandemics, a multi-institutional team involving Lawrence Livermore National Laboratory (LLNL) researchers has successfully combined an artificial intelligence (AI)-backed platform with supercomputing to redesign and restore the effectiveness of antibodies whose ability to fight viruses has been compromised by…
Brain-on-a-chip: Improving 3D neural network analysis
Brain-on-a-chip (BOC) systems are engineered cell-culture models that allow non-invasive, real-time monitoring of electrochemical processes. While newer 3D BOC systems have improved the neuronal viability, neural network activity, drug responses, and resemblance to disease pathology compared to their 2D counterparts, the ability to monitor the functional dynamics of the…
Anti-tumor immune responses in pancreatic cancer
Pancreatic ductal adenocarcinoma (PDAC) is one of the deadliest types of cancer with a limited survival rate of about 10% over five years. In general, by the time a patient presents symptoms, the disease has advanced to a surgically unresectable stage and likely metastasized to other vital organs leading to rapid mortality. Since conventional chemotherapy prolongs patients…
Celebrating LLNL researchers on World Intellectual Property Day
World Intellectual Property (IP) Day is Friday, April 26. World IP Day shines a light on the important role innovation plays in achieving the United Nations’ (UN) 17 Sustainable Development Goals (SDGs), which aim to create a better future for everyone by protecting the planet. Lawrence Livermore National Laboratory’s (LLNL)’s Innovation and Partnerships Office (IPO) is…
Mitigating the risk of infection in combat-related injuries
The severely invasive nature of combat trauma creates massive regions of injury, colonization and infection, requiring specialized diagnostic and aggressive therapeutic approaches. Previous reports indicate an estimated occurrence of wound infections in 18%–25% of combat-related injuries. Hindering wound recovery are multidrug-resistant microorganisms, which have been…
LLNL researcher, business development executive capture technology transfer award from consortium
A Lawrence Livermore National Laboratory (LLNL) researcher and a colleague who helped him and his team commercialize their biomedical technology have garnered a national technology transfer award. The award, from the Federal Laboratory Consortium (FLC), represents the 42nd technology transfer award that LLNL has won from the FLC since 1985. LLNL biologist Nicholas Fischer,…
Concentrating on rare-earth elements
Using a bioengineered protein-based technology, Lawrence Livermore National Laboratory (LLNL) scientists and collaborators will develop a new separation technique that ultimately will increase the concentration of rare-earth elements (REE) so they are more readily available to the defense sector. Under the Defense Advanced Research Projects Agency (DARPA) Environmental…
Algal activities shape surrounding bacterial communities
Microalgae play important roles in global carbon cycling and industrial applications for bioproduct and biofuel production. As with land plants and other host–microbial systems, microalgal activity, productivity, and stability are closely tied to surrounding microbial communities. However, a predictive understanding of microbial community interactions with algae is still…
‘Science on Saturday’ extends into March in Tracy
Lawrence Livermore National Laboratory’s (LLNL) popular outreach series, “Science on Saturday,” will continue its programming into March at the Grand Theatre Center for the Arts in Tracy, California. The talks are scheduled for March 2 and 9 and will focus on the theme “Magic of Materials.” The talks, which are geared toward middle and high school students, will begin at…
Using agricultural residues for fuel and chemicals
A Lawrence Livermore National Laboratory (LLNL) scientist is part of a research team shedding new light on how to access the sugars locked up in plant materials in order to convert byproducts into new feedstocks for production of fuels, materials and chemicals. Converting grasses, weeds, wood and other plant residues into sustainable products normally produced using…
Lawrence Livermore’s popular 'Science on Saturday' lecture series returns to Las Positas College
Lawrence Livermore National Laboratory's (LLNL) popular lecture series, “Science on Saturday,” returns Feb. 3 and runs through Feb. 24. The series offers four different lectures with the theme, “Magic of Materials.” Each lecture is presented by leading LLNL researchers who are joined by high-school science teachers. Below is the schedule of lectures, which can also be…
Synthetic antibacterial minerals combat topical infections
The development of new antibiotics has stalled — new strategies are needed as the world enters the age of antibiotic resistance. To combat this challenge, Lawrence Livermore National Laboratory (LLNL) scientists have found that synthetic antibacterial minerals exhibit potent antibacterial activity against topical MRSA infections and increase the rate of wound closure…
Two selected as Graduate Student Research program recipients
Two graduate students have earned Department of Energy (DOE) Office of Science Graduate Student Research (SCGSR) Program awards to perform their doctoral dissertation research at Lawrence Livermore National Laboratory (LLNL). The prestigious award helps cover living expenses and travel for 60 students from universities across the nation. Their proposed research projects…
PLS postdocs excel at the 2023 Research Slam
On Thursday, August 24, a dozen LLNL postdocs presented in the annual Postdoctoral Research Slam, answering the question “Why is my research important?” in only three minutes. Each talk was then evaluated by LLNL leadership, awarding first and second place to PLS postdocs Brandon Zimmerman and Aditya Prajapati, respectively. As a bonus, the attending audience voted on…
LLNL scientists use engineered bone marrow for cancer research and treatment
Osteosarcoma (OS) is the most common primary malignant bone cancer in children and adolescents. While many other cancers now have promising therapeutic advances, treatment options for OS have remained unchanged since the introduction of standard chemotherapeutics and offer less than a 25% five-year survival rate for those with metastatic disease. Now, Lawrence Livermore…
